Research ArticleClinical Studies

Adjuvant Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

MEHRAN BAGHI, MARKUS HAMBEK, ANGELIKA MAY, ANDREAS RADELOFF, WOLFGANG GSTOETTNER and RAINALD KNECHT
Anticancer Research January 2006, 26 (1B) 559-563;

Article Information

vol. 26 no. 1B 559-563
PMID 
16739320
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 20, 2005
  • Revision received November 9, 2005
  • Accepted November 16, 2005
  • Published online January 1, 2006.
Copyright & Usage 
Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. MEHRAN BAGHI,
  2. MARKUS HAMBEK,
  3. ANGELIKA MAY,
  4. ANDREAS RADELOFF,
  5. WOLFGANG GSTOETTNER and
  6. RAINALD KNECHT
  1. Department for ENT- Surgery, University of Frankfurt am Main, Germany
  1. Correspondence to: Rainald Knecht, MD, Ph.D., ENT Department of Johann Wolfgang Goethe University Clinic, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany. Tel: +49-69-63014471, Fax: +49-69-63017710, e-mail: knecht{at}em.uni-frankfurt.de

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Adjuvant Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
MEHRAN BAGHI, MARKUS HAMBEK, ANGELIKA MAY, ANDREAS RADELOFF, WOLFGANG GSTOETTNER, RAINALD KNECHT
Anticancer Research Jan 2006, 26 (1B) 559-563;
Twitter logo Facebook logo Mendeley logo

Jump to section